Author: Khawaja, Fareed; Chemaly, Roy F.
Title: Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies Document date: 2019_7_23
ID: 4fx18mlj_1
Snippet: I n the USA and other western nations, respiratory syncytial virus is one of the most commonly encountered respiratory viruses among patients who have been diagnosed with a hematologic malignancy or who have undergone a stem cell transplant. Multiple studies have been performed to evaluate the complications associated with respiratory syncytial virus infections. Other studies have evaluated therapeutic agents and strategies in which these agents .....
Document: I n the USA and other western nations, respiratory syncytial virus is one of the most commonly encountered respiratory viruses among patients who have been diagnosed with a hematologic malignancy or who have undergone a stem cell transplant. Multiple studies have been performed to evaluate the complications associated with respiratory syncytial virus infections. Other studies have evaluated therapeutic agents and strategies in which these agents can be used. There have also been numerous reports of outbreaks in bone marrow transplant units and oncology wards, where infection control measures have been invaluable in controlling the spread of disease. However, despite these novel approaches, respiratory syncytial virus continues to be potentially fatal in immunocompromised populations. In this review, we discuss the incidence of respiratory syncytial viral infections, risk factors associated with progression from upper respiratory tract infection to lower respiratory tract infection, other complications and outcomes (including mortality), management strategies, and prevention strategies in patients with a hematologic malignancy and in hematopoietic cell transplant recipients.
Search related documents:
Co phrase search for related documents- agent strategy and disease spread control: 1
- agent strategy and management strategy: 1
- cell transplant and disease spread: 1, 2
- cell transplant and disease spread control: 1
- cell transplant and hematologic malignancy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- cell transplant and hematopoietic cell transplant recipient: 1, 2, 3, 4, 5
- cell transplant and infection control: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- cell transplant recipient and hematologic malignancy: 1
- cell transplant recipient and hematopoietic cell transplant recipient: 1, 2, 3, 4, 5
- disease spread and hematologic malignancy: 1
- disease spread and infection control: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- disease spread and infection control measure: 1, 2
- disease spread and management strategy: 1, 2, 3, 4, 5, 6, 7, 8, 9
- disease spread and marrow transplant unit: 1
- disease spread and mortality include: 1, 2
- disease spread and multiple study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- disease spread control and hematologic malignancy: 1
- disease spread control and infection control: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- disease spread control and mortality include: 1
Co phrase search for related documents, hyperlinks ordered by date